Key result
Intra-arrest esmolol successfully treated refractory ventricular fibrillation in an undifferentiated trauma patient.
Why the study?
Does intra-arrest esmolol improve outcomes in undifferentiated trauma patients with refractory ventricular fibrillation?
Case Report (n=1)
Does intra-arrest esmolol improve outcomes in undifferentiated trauma patients with refractory ventricular fibrillation?
Intra-arrest esmolol may be considered as a treatment for refractory ventricular fibrillation even in undifferentiated traumatic arrest patients prior to cessation of resuscitation.
Answers are grounded in this paper and cite their sources.
Esmolol achieved ROSC in one traumatic refractory VF arrest; leaves open its role in undifferentiated trauma and requires prospective trials.
Here, we describe a case of refractory ventricular fibrillation (RVF) in an undifferentiated trauma patient that responded to intra-arrest esmolol. To our knowledge, this is the first case of RVF in an undifferentiated trauma patient that responded to intra-arrest esmolol. This case continues to support the growing evidence for use of esmolol as a treatment of refractory fibrillation and should be considered even in undifferentiated traumatic arrest patients prior to the cessation of resuscitation efforts.
No takes yet. Share an insight, caveat, or question.
Raymond et al. (2021) conducted a case report in Refractory ventricular fibrillation (n=1). Intra-arrest esmolol was evaluated on Response to treatment (successful resolution of refractory ventricular fibrillation). Intra-arrest esmolol successfully treated refractory ventricular fibrillation in an undifferentiated trauma patient.
Synapse has enriched 10 related papers. Consider them for comparative context: